It was reported that a cadd® administration set had an issue of serious underinfusion and leaking.The underinfusion was between 15% and 56%, and the patient was compromised and needed additional care.The patient required higher levels of monitoring.It was unclear what the impact to the patient was.See mfr: 3012307300-2017-00467, 3012307300-2017-00468, 3012307300-2017-00469, 3012307300-2017-00470, 3012307300-2017-00471, 3012307300-2017-00472, 3012307300-2017-00473, 3012307300-2017-00474, 3012307300-2017-00475, 3012307300-2017-00476, and 3012307300-2017-00477.
|